- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07408765
Physical Activity, Fatigue, Social Support, and Psychological Well-Being in Women With Primary Hypothyroidism
Physical Activity, Fatigue, Social Support, and Psychological Well-Being in Women With Primary Hypothyroidism: A Multicenter Observational Cohort Study
Background. Primary hypothyroidism, both clinical and subclinical, is frequently associated with persistent fatigue, reduced psychological well-being, and lower levels of physical activity in adult women. However, evidence integrating these psychosocial factors remains limited and methodologically heterogeneous.
Objective. To analyze the association between physical activity and fatigue, social support, and psychological well-being in women with primary hypothyroidism; to compare these profiles between clinical and subclinical hypothyroidism; and to explore the moderating effect of social support and psychological well-being on the relationship between fatigue and physical activity.
Methods. An observational, analytical, multicenter cohort study will be conducted including 96 adult women with primary hypothyroidism from the Principality of Asturias. Physical activity levels will be assessed using the International Physical Activity Questionnaire-Short Form (IPAQ-SF), while fatigue, social support, and psychological well-being will be measured using the Fatigue Severity Scale (FSS), the Medical Outcomes Study Social Support Survey (MOS-SSS), and the WHO-5 Well-Being Index, respectively. Confounding variables will include age, body mass index, type of hypothyroidism (clinical or subclinical), and time since diagnosis. Descriptive analyses, comparisons between clinical and subclinical groups, and multiple linear regression models will be performed.
Expected results. The study is expected to identify physical activity levels within the sample and determine which psychosocial factors are independently associated with physical activity. Additionally, fatigue is anticipated to be negatively associated with physical activity, whereas social support and psychological well-being are expected to show positive associations and potential moderating effects.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Rubén Cuesta-Barriuso, PhD
- Phone Number: 0034 985103386
- Email: cuestaruben@uniovi.es
Study Contact Backup
- Name: Rubén Cuesta-Barriuso, PhD
- Email: cuestaruben@uniovi.es
Study Locations
-
-
Principality of Asturias
-
Oviedo, Principality of Asturias, Spain, 33006
- Recruiting
- Universidad de Oviedo
-
Contact:
- Rubén Cuesta-Barriuso
- Phone Number: 607547274
- Email: cuestaruben@uniovi.es
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Have a diagnosis of primary hypothyroidism (clinical or subclinical), established by a specialist in Endocrinology or Internal Medicine based on TSH and FT4 levels.
- Female.
- Are aged ≥18 years at the time of inclusion.
- Have stable treatment for thyroid dysfunction (levothyroxine dose or other replacement regimen without relevant modifications) for at least the previous 3 months, or a stable clinical condition if treatment is not required.
- Are able to ambulate independently in the community (with or without usual assistive devices), allowing participation in light to moderate physical activity.
- Are able to understand and complete the questionnaires independently.
- Have provided written informed consent
Exclusion Criteria:
- Have a diagnosis of severe medical conditions that predominantly limit the ability to perform physical activity independently of hypothyroidism (e.g., advanced heart failure, severe chronic respiratory disease).
- Have severe psychiatric disorders or significant cognitive impairment that hinder understanding of the information or reliable completion of the questionnaires.
- Have undergone major surgery, severe trauma, or an acute medical condition that has substantially limited physical activity in the three months prior to assessment.
- Are pregnant or in the immediate postpartum period, due to potential hormonal and functional interference with the study variables.
- Are concurrently participating in a clinical trial or a structured physical exercise program.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Observational group
Women with primary hypothyroidism from the Principality of Asturias
|
To assess the level of physical activity in women with primary hypothyroidism and to identify the predictive model of physical activity in this population.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of habitual physical activity level
Time Frame: Screening visit
|
This variable will be assessed using the Spanish version of the International Physical Activity Questionnaire-Short Form (IPAQ-SF).
This instrument, widely used in clinical and population-based research, allows estimation of weekly energy expenditure in MET-minutes and classification of participants into low, moderate, or high physical activity categories.
|
Screening visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of perceived fatigue
Time Frame: Screening visit
|
This variable will be assessed using the Spanish-validated Fatigue Severity Scale (FSS).
The FSS is one of the most widely used instruments internationally to measure physical and mental fatigue in chronic conditions and consists of nine items rated on a 1-7 scale.
|
Screening visit
|
|
Measurement of perceived social support
Time Frame: Screening visit
|
This variable will be assessed using the Spanish version of the Medical Outcomes Study Social Support Survey (MOS-SSS).
This 19-item questionnaire evaluates four dimensions of support (emotional/informational, instrumental, affectionate, and positive social interaction).
|
Screening visit
|
|
Measurement of psychological well-being
Time Frame: Screening visit
|
This variable will be assessed using the Spanish version of the WHO-5 Well-Being Index.
This five-item instrument evaluates subjective well-being over the previous two weeks and its use in research is recommended by the World Health Organization.
|
Screening visit
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of age
Time Frame: Screening visit
|
This potential confounding or moderating variable, which may influence the relationship between physical activity and psychosocial factors, will be assessed in years.
|
Screening visit
|
|
Measurement of body mass index
Time Frame: Screening visit
|
This potential confounding or moderating variable, which may influence the relationship between physical activity and psychosocial factors, will be calculated from body mass and height (kg/m²).
|
Screening visit
|
|
Measurement of type of hypothyroidism
Time Frame: Screening visit
|
This potential confounding or moderating variable, which may influence the relationship between physical activity and psychosocial factors, will be classified as clinical or subclinical primary hypothyroidism based on TSH and FT4 levels.
|
Screening visit
|
|
Measurement of time since diagnosis
Time Frame: Screening visit
|
This potential confounding or moderating variable, which may influence the relationship between physical activity and psychosocial factors, will be assessed in years.
|
Screening visit
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HipotAct
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypothyroidism Primary
-
University of PennsylvaniaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruiting
-
University of CopenhagenRecruiting
-
University Hospital DubravaRecruitingHypothyroidism PrimaryCroatia
-
Walter Reed National Military Medical CenterUnknownPrimary Hypothyroidism.United States
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do SulUnknownAging | Interaction Drug Food | Primary HypothyroidismBrazil
-
Sohag UniversityRecruitingPrimary Hypothyroidism | Non-Diabetic Patients | Overt | Sub-clinical | Metabolic Dysfunction-Associated Steatoic Liver DiseaseEgypt
-
Georgetown UniversityCompletedHypothyroidism Primary
-
King Edward Medical UniversityCompletedDyslipidemias | Lipid Disorder | Hypothyroidism PrimaryPakistan
-
Assiut UniversityEnrolling by invitationHypothyroidism PrimaryEgypt
-
Cairo UniversityCompletedAcupuncture | PCO | Primary Hypothyroidism | Irregular MenstruationEgypt
Clinical Trials on Women with primary hypothyroidism sample
-
Assiut UniversityNot yet recruitingHighlight the Most Important Preventable Factors That May Help Decrease Rate of Ceaseran Section in Egypt
-
Sohag UniversityRecruiting
-
Syracuse VA Medical CenterNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not yet recruiting
-
French Cardiology SocietyAstraZeneca; Daiichi Sankyo, Inc.; Boston Scientific Corporation; Abbott Medical... and other collaboratorsCompletedAcute Myocardial Infarction | Women Over 18 and Under 50 Years of AgeFrance
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR)Completed
-
University of Applied Sciences of Western SwitzerlandClaire de Labrusse; Sandrine Balisson; Léa DassonvilleCompletedUrinary Incontinence | Stress Urinary IncontinenceSwitzerland
-
VA Office of Research and DevelopmentCompletedDepression | Anxiety | Stress Disorders, Post TraumaticUnited States
-
Sakarya UniversityCompleted
-
Konya City HospitalCompleted
-
Shanghai Zhongshan HospitalRecruitingST-segment Elevation Myocardial Infarction (STEMI)China